PRURIGO NODULARIS
Clinical trials for PRURIGO NODULARIS explained in plain language.
Never miss a new study
Get alerted when new PRURIGO NODULARIS trials appear
Sign up with your email to follow new studies for PRURIGO NODULARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to stop uncontrollable itch for skin condition sufferers
Disease control OngoingThis study is testing whether an investigational drug called rocatinlimab can reduce severe itching and improve skin lesions in adults with prurigo nodularis, a chronic skin condition. Participants will receive either the drug or a placebo for 52 weeks to see which is more effect…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Amgen • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
3.5-Year trial tests Long-Term relief for debilitating skin condition
Disease control OngoingThis study aims to assess the long-term safety and effectiveness of nemolizumab, an injectable medication, for people with prurigo nodularis—a chronic skin disease causing intense itch and hard bumps. It will follow about 500 participants who previously took the drug in earlier s…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE3 • Sponsor: Galderma R&D • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC
-
New shot aims to stop debilitating skin itch
Symptom relief OngoingThis study is testing an investigational drug called barzolvolimab to see if it can safely reduce severe itching and improve skin lesions in adults with prurigo nodularis. About 140 participants will receive either the drug or a placebo via injection every four weeks for 24 weeks…
Matched conditions: PRURIGO NODULARIS
Phase: PHASE2 • Sponsor: Celldex Therapeutics • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC
-
Tracking a skin Treatment's Real-World impact
Knowledge-focused OngoingThis study aims to understand how well the medication dupilumab works for adults with prurigo nodularis, a severe itchy skin condition, in everyday medical practice. It will follow 100 patients for up to 18 months to see how their symptoms, like itch and pain, change and how the …
Matched conditions: PRURIGO NODULARIS
Sponsor: Sanofi • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:15 UTC